Product

Company

Clareo Health | Observational Study of Iris Tumors

NCT03809585·1 site·ClinicalTrials.gov

Take this into the appointment.

Saves the questions and what to expect into your notes, next to the visit they belong to.

Keep this study

Lead

Oregon Health and Science University

With

Age

18–any

Sex

ALL

Healthy volunteers

Accepted

Inability to give informed consent
Inability to maintain stable fixation for OCT imaging
Inability to commit to required study visits
Eyes with concurrent retinal diseases, glaucoma, or conditions that in the opinion of the investigators might affect iris circulation
Mature cataracts if found to limit visual potential to worse than 20/40

The record

StatusRecruiting

PhaseNo phase

Taking part100

StartedJun 2018

UpdatedSep 9, 2025

Conditions

Where1